ISOREA has been Awarded the Eureka Eurostars Grant!
We are thrilled to announce that ISOREA AB, in collaboration with Karolinska Institutet and Davids Biotechnologie GmbH , has been awarded a prestigious Eureka Eurostars grant and the project will start from April 2025! This achievement represents a major step forward in our mission to revolutionise Alzheimer’s Disease detection by identifying the risks 6–10 years before noticeable symptoms develop and are possible to treat at this stage.
Eurostars is highly regarded for fostering collaborative and market-focused R&D initiatives, and we are privileged to join this dynamic community of innovators Eureka Network. This grant will accelerate our efforts in advancing research and expanding the application of our antibodies for early risk detection of Alzheimer’s Disease.
We extend our heartfelt thanks to our CEO, Sourav Pr. Mukherjee, Ph.D., for leading the consortium and coordinating this remarkable project, as well as to Professor Roman Zubarev from Karolinska Institutet and Dr. Michael Davids from Davids Biotechnologie for their invaluable contributions. Together, this collaborative effort has paved the way for this achievement. We are excited for the journey ahead, driven by innovation, teamwork, and impactful advancements.
Stay tuned as we dive into this exciting new chapter—we’re thrilled to share our journey and updates with you every step of the way!
